Proceedings: Differentiation between neuroleptic antipsychotic properties and side effects by subgroups of dopaminergic neurons.
D000818:Animals; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors; D004298:Dopamine / Q000502:physiology*; D005246:Feedback; D006801:Humans; D009474:Neurons / Q000187:drug effects*; D011618:Psychotic Disorders / Q000188:drug therapy*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use
D011955:Receptors, Drug; D014149:Tranquilizing Agents; D003913:Dextroamphetamine; D004298:Dopamine